Back to homepage

Tag "cardiovascular disease"

New and emerging lipid-modifying drugs to lower LDL cholesterol

Authors: Constantine E Kosmas, Dafni Pantou, Andreas Sourlas, Evangelia J Papakonstantinou, Rogers Echavarria Uceta, Eliscer Guzman

This review aims to present and discuss the current clinical and scientific data pertaining to the new and emerging lipid-modifying low-density lipoprotein-cholesterol-lowering drugs.

More

Clinical potential of treatment with semaglutide in type 2 diabetes patients

Authors: Michael E Røder

This review discusses the efficacy and safety of semaglutide, which have
been investigated in an extensive clinical development
program including more than 9,000 patients with type 2
diabetes.

More

Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues

Authors: Ashutosh M Shukla MD, Aparna Wagle Shukla MD

This article reviews the expanding clinical applicability of chloroquine and related drugs includes rheumatological and cardiovascular disorders (CVD), chronic kidney disease (CKD), oncology, and a variety of nonmalarial infections.

More

Therapeutic management of hyperlipoproteinemia (a)

Authors: Constantine E Kosmas MD, PhD, Andreas Sourlas, Gordon Mallarkey PhD, Delia Silverio MD, Domingo Y Ynoa MD, Peter D Montan MD, Eliscer Guzman MD, Mario J Garcia MD

This review presents and discusses the current clinical and scientific data pertaining to the therapeutic options for the management of hyperlipoproteinemia (a).

More

Combination therapy in the treatment of hypertension

Authors: Carolina Guerrero-García MD, Alberto Francisco Rubio-Guerra PhD

This article reviews the latest information available regarding the treatment of hypertension with combination therapy.

More